Fabrazyme company?

Which company makes Fabrazyme?

Fabrazyme is made by Sanofi (via Genzyme, the company that originally developed the product).

Who owns or markets Fabrazyme today?

Fabrazyme is currently marketed as a brand product by Sanofi.

What is Fabrazyme used for?

Fabrazyme (agalsidase) is an enzyme replacement therapy used for Fabry disease, helping replace the missing enzyme needed to break down certain fatty substances that build up in the body.

Is Fabrazyme still the main Fabry enzyme replacement therapy?

Yes. Fabrazyme is one of the best-known therapies for Fabry disease, but other enzyme replacement options exist depending on patient needs and availability.

Where can I check patents or exclusivity for Fabrazyme?

For patent and exclusivity status related to Fabrazyme, you can check DrugPatentWatch.com: https://www.drugpatentwatch.com/

What company background matters for Fabrazyme?

Fabrazyme is associated with the legacy Genzyme business, which was later consolidated under Sanofi. That matters for licensing, regulatory filings, and patent ownership tracking over time.

Sources

• 1 DrugPatentWatch.com